Showing results (251-260 of 396) with videos related to

Sort By:
Pageof 40
Leukemia|April 1, 1996
Oral idarubicin pharmacokinetics--correlation of trough level with idarubicin area under curveE Schleyer, S Kühn, H Rührs, et al.
British Journal of Haematology|August 10, 2000
The pharmacodynamic basis for the increased antileukaemic efficacy of cytosine arabinoside-based treatment regimens in acute myeloid leukaemia with a high proliferative activityJ Braess, S Voss, G Jahns-Streubel, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2001
Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II studyR D Issels, S Abdel-Rahman, C Wendtner, et al.
Leukemia|March 10, 2001
Cytogenetic subgroups in acute myeloid leukemia differ in proliferative activity and response to GM-CSFG Jahns-Streubel, J Braess, C Schoch, et al.
Leukemia|June 1, 1992
Intracellular cytosine arabinoside accumulation and cytosine arabinoside triphosphate formation in leukemic blast cells is inhibited by etoposide and teniposideG Ehninger, B Proksch, T Wanner, et al.
Leukemia|January 22, 1998
Oral idarubicin pharmacokinetics--correlation of trough level with idarubicin area under curveE Schleyer, S Kühn, H Rührs, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2001
Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermiaC Wendtner, S Abdel-Rahman, J Baumert, et al.
Blood|October 15, 1995
Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulationsD Haase, M Feuring-Buske, S Könemann, et al.
Schweizerische Medizinische Wochenschrift|April 23, 1988
[Clinical course and risk factors in patients with generalized mycoses]M von Eiff, M Essink, W Fegeler, et al.
Blood|September 18, 1997
Activity of thymidine kinase and of polymerase alpha as well as activity and gene expression of deoxycytidine deaminase in leukemic blasts are correlated with clinical response in the setting of granulocyte-macrophage colony-stimulating factor-based priming before and during TAD-9 induction therapy in acute myeloid leukemiaG Jahns-Streubel, C Reuter, U Auf der Landwehr, et al.
Pageof 40